Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Diabetic Peripheral Neuropathic Pain in China
NCT01179672Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in diabetic polyneuropathy (DPN), sponsored by Eli Lilly and Company. Started Apr 2011; status: completed.
02
Drugs
duloxetine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT01179672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179672.